Cantel Medical Corp. (NYSE:CMD) is set to announce first quarter earning results on Tuesday 8th December 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, CMD to report 1Q21 income of $ 0.37 per share.
For the full year, analysts anticipate top line of $ 1129.23 million, while looking forward to income of $ 1.65 per share bottom line.
The Company Outlook
Revenue for 1Q21 are expected in a range of $ 290.00 million ~ $ 295.00 million
Click Here For More Historical Outlooks Of Cantel Medical Corp.
Previous Quarter Performance
Cantel Medical Corp. unveiled income for the fourth quarter of $ 0.24 per share, from the revenue of $ 233.37 million. The quarterly earnings declined 61.90 percent while revenues decreased 2.55 percent compared with the same quarter last year. The top line results outshined analysts by $ 9.73 million or 4.35 percent.
Stock Performance
Shares of Cantel Medical Corp. traded low $ -1.58 or -2.50 percent on Monday, reaching $ 61.60 with volume of 623.70 thousand shares. Cantel Medical Corp. has traded high as $ 64.36 and has cracked $ 60.94 on the downward trend
According to the previous trading day, closing price of $ 61.60, representing a 203.60 % increase from the 52 week low of $ 20.81 and a 20.53 % decrease over the 52 week high of $ 79.50.
The company has a market capital of $ 2.60 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Conference Call
Cantel Medical Corp. will be hosting a conference call at 8:30 AM eastern time on 8th December 2020, to discuss its 1Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.cantelmedical.com
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The companys Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
